Onapristone extended-release compositions and methods
US11672762B2 · kind B2 · utility
0Cited by
22References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2020 |
| Grant date | Jun 13, 2023 |
| Priority date | — |
| Expiry date | Sep 28, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.